nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—ABCB1—Allograft Rejection—IL4—periodontitis	0.00347	0.00347	CbGpPWpGaD
Citalopram—SLC6A4—Circadian rythm related genes—NOS2—periodontitis	0.00342	0.00342	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00339	0.00339	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00338	0.00338	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00333	0.00333	CbGpPWpGaD
Citalopram—CYP1A2—Phase II conjugation—GGT1—periodontitis	0.00316	0.00316	CbGpPWpGaD
Citalopram—ABCB1—HIF-1-alpha transcription factor network—NOS2—periodontitis	0.00316	0.00316	CbGpPWpGaD
Citalopram—CYP2B6—Biological oxidations—GGT1—periodontitis	0.00314	0.00314	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00312	0.00312	CbGpPWpGaD
Citalopram—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00308	0.00308	CbGpPWpGaD
Citalopram—CYP2E1—Biological oxidations—GGT1—periodontitis	0.00308	0.00308	CbGpPWpGaD
Citalopram—CHRM1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00307	0.00307	CbGpPWpGaD
Citalopram—HRH1—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00307	0.00307	CbGpPWpGaD
Citalopram—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00306	0.00306	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—NTRK1—periodontitis	0.00306	0.00306	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00305	0.00305	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00303	0.00303	CbGpPWpGaD
Citalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00302	0.00302	CbGpPWpGaD
Citalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00301	0.00301	CbGpPWpGaD
Citalopram—SLC6A4—SIDS Susceptibility Pathways—CXCL8—periodontitis	0.00299	0.00299	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—CXCR2—periodontitis	0.00298	0.00298	CbGpPWpGaD
Citalopram—CYP2C19—Arachidonic acid metabolism—PTGS2—periodontitis	0.00297	0.00297	CbGpPWpGaD
Citalopram—SLC6A4—SIDS Susceptibility Pathways—IL1B—periodontitis	0.00287	0.00287	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.0027	0.0027	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00269	0.00269	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00265	0.00265	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00264	0.00264	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00263	0.00263	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00263	0.00263	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00262	0.00262	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CXCL3—periodontitis	0.00261	0.00261	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00259	0.00259	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—CXCR2—periodontitis	0.00258	0.00258	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—periodontitis	0.00258	0.00258	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00258	0.00258	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—CXCR2—periodontitis	0.00258	0.00258	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—CXCR2—periodontitis	0.00254	0.00254	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—periodontitis	0.00247	0.00247	CbGpPWpGaD
Citalopram—CYP2C19—Biological oxidations—GGT1—periodontitis	0.00238	0.00238	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CXCL3—periodontitis	0.00237	0.00237	CbGpPWpGaD
Citalopram—SLC6A4—NRF2 pathway—TGFB1—periodontitis	0.00235	0.00235	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—CCR2—periodontitis	0.00232	0.00232	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—PPARA—periodontitis	0.00232	0.00232	CbGpPWpGaD
Citalopram—CYP1A2—Arachidonic acid metabolism—PTGS2—periodontitis	0.00231	0.00231	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—ADRB1—periodontitis	0.00231	0.00231	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—periodontitis	0.0023	0.0023	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CXCL3—periodontitis	0.00227	0.00227	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CXCL3—periodontitis	0.00226	0.00226	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CXCL3—periodontitis	0.00222	0.00222	CbGpPWpGaD
Citalopram—CYP2D6—Biological oxidations—GGT1—periodontitis	0.00218	0.00218	CbGpPWpGaD
Citalopram—CHRM1—Regulation of Actin Cytoskeleton—FGF2—periodontitis	0.00212	0.00212	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—IFNG—periodontitis	0.0021	0.0021	CbGpPWpGaD
Citalopram—SLC6A4—SIDS Susceptibility Pathways—TNF—periodontitis	0.00208	0.00208	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CXCL3—periodontitis	0.00206	0.00206	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CXCL3—periodontitis	0.00205	0.00205	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—NOS2—periodontitis	0.00205	0.00205	CbGpPWpGaD
Citalopram—SLC6A2—NRF2 pathway—TGFB1—periodontitis	0.00202	0.00202	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CXCL3—periodontitis	0.00202	0.00202	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.00201	0.00201	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—CCR2—periodontitis	0.00201	0.00201	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—CCR2—periodontitis	0.002	0.002	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—ADRB1—periodontitis	0.002	0.002	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—ADRB1—periodontitis	0.00199	0.00199	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—CCR2—periodontitis	0.00197	0.00197	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—ADRB1—periodontitis	0.00196	0.00196	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—CXCL8—periodontitis	0.00195	0.00195	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—VIP—periodontitis	0.00189	0.00189	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—IL1B—periodontitis	0.00187	0.00187	CbGpPWpGaD
Citalopram—CYP1A2—Biological oxidations—GGT1—periodontitis	0.00185	0.00185	CbGpPWpGaD
Citalopram—SLC6A3—NRF2 pathway—TGFB1—periodontitis	0.00179	0.00179	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	0.00179	0.00179	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—VIP—periodontitis	0.00172	0.00172	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CXCR2—periodontitis	0.00169	0.00169	CbGpPWpGaD
Citalopram—SLC6A4—SIDS Susceptibility Pathways—IL6—periodontitis	0.00168	0.00168	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—TNF—periodontitis	0.00167	0.00167	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	0.00167	0.00167	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—SLC52A3—periodontitis	0.00164	0.00164	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—VIP—periodontitis	0.00164	0.00164	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—VIP—periodontitis	0.00163	0.00163	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—VIP—periodontitis	0.00161	0.00161	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—SLC52A3—periodontitis	0.00161	0.00161	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CXCR2—periodontitis	0.00153	0.00153	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.0015	0.0015	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—VIP—periodontitis	0.00149	0.00149	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—VIP—periodontitis	0.00148	0.00148	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CXCR2—periodontitis	0.00146	0.00146	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—VIP—periodontitis	0.00146	0.00146	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CXCR2—periodontitis	0.00146	0.00146	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—TGFB1—periodontitis	0.00145	0.00145	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CXCR2—periodontitis	0.00143	0.00143	CbGpPWpGaD
Citalopram—CYP3A4—Biological oxidations—GGT1—periodontitis	0.00143	0.00143	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCL3—periodontitis	0.0014	0.0014	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—PPARA—periodontitis	0.00138	0.00138	CbGpPWpGaD
Citalopram—SLC6A4—Circadian rythm related genes—IL6—periodontitis	0.00137	0.00137	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—TNF—periodontitis	0.00136	0.00136	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CXCR2—periodontitis	0.00133	0.00133	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CXCR2—periodontitis	0.00132	0.00132	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CCR2—periodontitis	0.00131	0.00131	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—ADRB1—periodontitis	0.0013	0.0013	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CXCR2—periodontitis	0.0013	0.0013	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.0013	0.0013	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.0013	0.0013	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00128	0.00128	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—SLC52A3—periodontitis	0.00124	0.00124	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—PPARA—periodontitis	0.00122	0.00122	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCL3—periodontitis	0.00122	0.00122	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCL3—periodontitis	0.00121	0.00121	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—SLC52A3—periodontitis	0.00121	0.00121	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCL3—periodontitis	0.00119	0.00119	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CCR2—periodontitis	0.00119	0.00119	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00119	0.00119	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—ADRB1—periodontitis	0.00118	0.00118	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—CCL2—periodontitis	0.00114	0.00114	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—SLC52A3—periodontitis	0.00114	0.00114	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CCR2—periodontitis	0.00114	0.00114	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CCR2—periodontitis	0.00113	0.00113	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—ADRB1—periodontitis	0.00113	0.00113	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—ADRB1—periodontitis	0.00113	0.00113	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CCR2—periodontitis	0.00111	0.00111	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—ADRB1—periodontitis	0.00111	0.00111	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.0011	0.0011	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CCR2—periodontitis	0.00103	0.00103	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00103	0.00103	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CCR2—periodontitis	0.00103	0.00103	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—ADRB1—periodontitis	0.00103	0.00103	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00102	0.00102	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—ADRB1—periodontitis	0.00102	0.00102	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—VIP—periodontitis	0.00101	0.00101	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CCR2—periodontitis	0.00101	0.00101	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00101	0.00101	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—ADRB1—periodontitis	0.00101	0.00101	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.000992	0.000992	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—CCL2—periodontitis	0.00099	0.00099	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—CCL2—periodontitis	0.000987	0.000987	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—CCL2—periodontitis	0.000972	0.000972	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ACP5—periodontitis	0.000966	0.000966	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—SLC52A3—periodontitis	0.000965	0.000965	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ACP5—periodontitis	0.000946	0.000946	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000912	0.000912	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCR2—periodontitis	0.000904	0.000904	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—CXCL8—periodontitis	0.000903	0.000903	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—MMP3—periodontitis	0.000902	0.000902	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.0009	0.0009	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—VIP—periodontitis	0.000879	0.000879	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—VIP—periodontitis	0.000876	0.000876	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—VIP—periodontitis	0.000862	0.000862	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—IL6—periodontitis	0.00082	0.00082	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCR2—periodontitis	0.000783	0.000783	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—CXCL8—periodontitis	0.000783	0.000783	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—MMP3—periodontitis	0.000781	0.000781	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCR2—periodontitis	0.000781	0.000781	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—CXCL8—periodontitis	0.00078	0.00078	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00078	0.00078	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—MMP3—periodontitis	0.000779	0.000779	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000777	0.000777	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCR2—periodontitis	0.000769	0.000769	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—CXCL8—periodontitis	0.000768	0.000768	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—MMP3—periodontitis	0.000767	0.000767	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000765	0.000765	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SLC52A3—periodontitis	0.000745	0.000745	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ACP5—periodontitis	0.00073	0.00073	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000717	0.000717	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ACP5—periodontitis	0.000713	0.000713	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000711	0.000711	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCR2—periodontitis	0.000703	0.000703	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ADRB1—periodontitis	0.0007	0.0007	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ACP5—periodontitis	0.000672	0.000672	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.00067	0.00067	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000653	0.000653	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCR2—periodontitis	0.000609	0.000609	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCR2—periodontitis	0.000607	0.000607	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ADRB1—periodontitis	0.000606	0.000606	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	0.000606	0.000606	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ADRB1—periodontitis	0.000604	0.000604	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCR2—periodontitis	0.000598	0.000598	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ADRB1—periodontitis	0.000595	0.000595	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CCL2—periodontitis	0.000586	0.000586	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NTRK1—periodontitis	0.000573	0.000573	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ACP5—periodontitis	0.000569	0.000569	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GGT1—periodontitis	0.000538	0.000538	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MMP3—periodontitis	0.000533	0.000533	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GGT1—periodontitis	0.000526	0.000526	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CXCL8—periodontitis	0.000511	0.000511	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000509	0.000509	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CCL2—periodontitis	0.000508	0.000508	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CCL2—periodontitis	0.000506	0.000506	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CCL2—periodontitis	0.000499	0.000499	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NTRK1—periodontitis	0.000497	0.000497	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NTRK1—periodontitis	0.000495	0.000495	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NTRK1—periodontitis	0.000487	0.000487	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CXCL8—periodontitis	0.000464	0.000464	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MMP3—periodontitis	0.000462	0.000462	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MMP3—periodontitis	0.00046	0.00046	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MMP3—periodontitis	0.000453	0.000453	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CXCL8—periodontitis	0.000442	0.000442	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CXCL8—periodontitis	0.000441	0.000441	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ACP5—periodontitis	0.000439	0.000439	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CXCL8—periodontitis	0.000434	0.000434	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000424	0.000424	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GGT1—periodontitis	0.000406	0.000406	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CXCL8—periodontitis	0.000402	0.000402	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CXCL8—periodontitis	0.0004	0.0004	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GGT1—periodontitis	0.000396	0.000396	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CXCL8—periodontitis	0.000394	0.000394	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PPARA—periodontitis	0.000385	0.000385	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PPARA—periodontitis	0.000377	0.000377	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GGT1—periodontitis	0.000374	0.000374	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCL2—periodontitis	0.000346	0.000346	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000331	0.000331	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GGT1—periodontitis	0.000316	0.000316	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—FGF2—periodontitis	0.000313	0.000313	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCL2—periodontitis	0.0003	0.0003	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCL2—periodontitis	0.000299	0.000299	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCL2—periodontitis	0.000295	0.000295	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PPARA—periodontitis	0.000291	0.000291	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PPARA—periodontitis	0.000284	0.000284	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCL8—periodontitis	0.000274	0.000274	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—FGF2—periodontitis	0.000271	0.000271	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—FGF2—periodontitis	0.00027	0.00027	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PPARA—periodontitis	0.000267	0.000267	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—FGF2—periodontitis	0.000266	0.000266	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6—periodontitis	0.00026	0.00026	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTGS2—periodontitis	0.00025	0.00025	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MMP9—periodontitis	0.000248	0.000248	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTGS2—periodontitis	0.000245	0.000245	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GGT1—periodontitis	0.000244	0.000244	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCL8—periodontitis	0.000237	0.000237	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCL8—periodontitis	0.000237	0.000237	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCL8—periodontitis	0.000233	0.000233	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPARA—periodontitis	0.000227	0.000227	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6—periodontitis	0.000226	0.000226	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6—periodontitis	0.000225	0.000225	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6—periodontitis	0.000221	0.000221	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MMP9—periodontitis	0.000215	0.000215	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MMP9—periodontitis	0.000214	0.000214	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MMP9—periodontitis	0.000211	0.000211	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TGFB1—periodontitis	0.000204	0.000204	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTGS2—periodontitis	0.000189	0.000189	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTGS2—periodontitis	0.000184	0.000184	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TGFB1—periodontitis	0.000177	0.000177	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TGFB1—periodontitis	0.000176	0.000176	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPARA—periodontitis	0.000175	0.000175	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTGS2—periodontitis	0.000174	0.000174	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TGFB1—periodontitis	0.000174	0.000174	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6—periodontitis	0.000154	0.000154	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTGS2—periodontitis	0.000147	0.000147	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6—periodontitis	0.000133	0.000133	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6—periodontitis	0.000133	0.000133	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6—periodontitis	0.000131	0.000131	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTGS2—periodontitis	0.000114	0.000114	CbGpPWpGaD
